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Abstract
Objectives: The primary objective of this study was to identify the existence of chronic disease multimorbidity patterns in
the primary care population, describing their clinical components and analysing how these patterns change and evolve over
time both in women and men. The secondary objective of this study was to generate evidence regarding the
pathophysiological processes underlying multimorbidity and to understand the interactions and synergies among the
various diseases.
Methods: This observational, retrospective, multicentre study utilised information from the electronic medical records of 19
primary care centres from 2008. To identify multimorbidity patterns, an exploratory factor analysis was carried out based on
the tetra-choric correlations between the diagnostic information of 275,682 patients who were over 14 years of age. The
analysis was stratified by age group and sex.
Results: Multimorbidity was found in all age groups, and its prevalence ranged from 13% in the 15 to 44 year age group to
67% in those 65 years of age or older. Goodness-of-fit indicators revealed sample values between 0.50 and 0.71. We
identified five patterns of multimorbidity: cardio-metabolic, psychiatric-substance abuse, mechanical-obesity-thyroidal,
psychogeriatric and depressive. Some of these patterns were found to evolve with age, and there were differences between
men and women.
Conclusions: Non-random associations between chronic diseases result in clinically consistent multimorbidity patterns
affecting a significant proportion of the population. Underlying pathophysiological phenomena were observed upon which
action can be taken both from a clinical, individual-level perspective and from a public health or population-level perspective.
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Introduction
The simultaneous occurrence of various health problems in a
given individual, which is defined as multimorbidity, has become
the norm rather than the exception [1,2]. Improved socio-economic
and living conditions and scientific and technological advances in
the field of healthcare have allowed a significant proportion of the
population to survive diseases that were previously fatal, and as a
result, health problems can accumulate in older population groups.
A recent review conducted by Marengoni showed that the
prevalence of multimorbidity in the elderly population is as high
as 98% [3]. However, this phenomenon is not confined to elderly
populations; its prevalence is also higher than expected for younger
age groups and for both sexes [1,4].
Understanding the types of multimorbidity patterns that appear
in the elderly, especially the chronic diseases that comprise these
patterns, demands an analysis of what happens in the earlier stages
of life, how those patterns are shaped from a young age, in what
way these diseases are aggregated, which diseases are associated
with each other and which are not, as well as the pathophysio-
logical mechanisms that may explain these associations. An
improved global understanding of the disease process and the
interactions present in an affected individual, rather than the study
of individual diseases, is essential so that health systems can design
appropriate and timely strategies for raising awareness and
improving preventative and clinical approaches to multimorbidity,
which currently is a health problem in and of itself [5].
Multimorbidity has extraordinary importance not only for the
general population but also for healthcare systems. It has been
shown to be associated with increased mortality [6], poor functional
status [7], lower quality of life [8], overloaded care, especially at the
primary care level [9] but also in the emergency room [10], and the
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on prescription drugs has significantly increased, and there has been
a greater frequency of inappropriate prescriptions as a result of this
clinical and social phenomenon [9].
Despite these results, there are very few studies that have
analysed multimorbidity in depth; for example, it is unknown to
what degree multimorbidity is caused by chance, how multi-
morbidity patterns differ between age and sex groups, what the
possible existence of index diseases is that would in turn give rise to
new symptoms and diseases or what the roles of iatrogenic issues
are in this phenomenon. Some of these aspects need to be
addressed promptly.
There are three main methodological reasons for this lack of
evidence:
1. First, there is uncertainty among the scientific community
regarding the application of statistical methods for the
exploration of simultaneously occurring health problems
[6,12]. In fact, most studies to date are based on counts of
the number of health problems, or the proportion of people
with pairs of conditions [13,14]. However, a major limitation of
this approach is that it cannot distinguish between statistically
significant associations and those that occur simply by chance.
It could be intuitively expected that diseases are either
concentrated in an individual if one disease is directly
responsible for the others (i.e., complicating multimorbidity)
or if they all share common or correlated risk factors (i.e.,
causal multimorbidity) [2]. The possible existence of additional
disease mechanisms beyond those of a pathophysiological
nature, which make certain disease associations appear more
often than expected simply by chance has also been suggested
(i.e., cluster multimorbidity) [15]. Among these, socio-econom-
ic, cultural, environmental and behavioural factors have been
described as related to patient complexity [16,17].
2. Moreover, progress towards understanding the causes of multi-
morbidity requires a standardised conceptualisation of the
various clinical entities that compose it, as the number and type
of diseases together with the various ways of grouping them can
significantly affect estimates of the prevalence of multimorbidity
and the strength of the identified associations [18]. The
interactions between chronic diseases are of particular interest
from the perspective of both health and healthcare. However,
serving as an additional methodological limitation, there is
currently no agreed-upon systematic categorisation of chronic
diseases within the scientific community.
3. Finally, the performance of large-scale population studies
focused on this and other public health problems requires
sources of information of proven quality that are accessible to
the entire scientific community. In this regard, it is important to
highlight the enormous potential of clinical-administrative
databases, which are available as a result of the computerisa-
tion of medical records in both primary and specialised care.
Compared with studies that have been based on survey results,
these databases provide access to diagnostic information at the
individual and population levels.
With respect to these three aspects, this work was based on a
statistical methodology that allowed for the identification of
statistically relevant patterns of multimorbidity. It applied a
previously validated categorisation system for chronic diseases
and used diagnostic information from primary care electronic
medical records.
The primary objective of this study was to identify the existence
of chronic disease multimorbidity patterns in the primary care
population, describing their clinical components and analysing
how these patterns change and evolve over time both in women
and men. The secondary objective of this study was to generate
evidence regarding the pathophysiological processes underlying
multimorbidity and to understand the interactions and synergies
among the various diseases.
The hypothesis was that there would be patterns of multi-
morbidity partially expected, predictable and explainable that
evolve along patients’ life. Such patterns would be composed of risk
factors in the early stages of life, of organ disorders in the middle
ages, and of disease-related complications in the later years of life.
Healthcare systems should consider the resulting evidence when
organisingand planningtheir service offerings. Moreover, this study
pretends to generate new hypotheses related to unknown causal
mechanisms underlying multimorbidity such as iatrogenic effects.
Methods
Design, study population and variables
This multicentre, retrospective, observational study was performed
in primary care centres of the Spanish National Health System. From
1986 on, Spain has a tax-based health system with universal coverage
for the entire population. The primary care model is based on
multidisciplinary teams consisting of family physicians and nurses.
The former coordinate prevention, health promotion, treatment, and
community care and they also act as gatekeepers to the healthcare
system and therefore to more specialized care. Each team has a
geographically delimited population assigned to it and all types of
patients and health problems, except for medical emergencies, are
initially attended in primary care centres.
The selection of centres to participate in this study was
conducted based on the following quality inclusion criteria: (a)
centres with computerised records for all appointments and with
more than two years of experience using this system by all
physicians and nurses, (b) those with a percentage of uncoded
episodes less than 20%, (c) those with a percentage of notes (e.g.,
prescription, observation, etc.) listed in uncoded episodes less than
15%, (d) those with a percentage of prescriptions linked to
uncoded episodes less than 10%, (e) those with an average number
of diagnoses higher than 3.5, and (f) those with a percentage of
patients with no diagnostic information less than 10%.
After selecting the centres, all patients over the age of 14 who
were seen at least once during 2008 by their family doctor were
included in the study. The study population was composed of
275,682 individuals belonging to 19 urban health centres (7 in
Arago ´n and 12 in Catalonia). For each of the patients included in
the study, demographic and diagnostic variables were extracted
from electronic medical records, including the age of the patient as
of December 31, 2008, the sex of the patient, and the chronic
diagnoses coded according to the International Classification of
Primary Care (ICPC) [19]. The diagnostic data included a
comprehensive overview of patients’ chronic diseases assigned
until end of 2008, for which there had been an annotation in the
medical record (e.g., prescription, observation, etc.) at some point
during the study year (i.e., 2008).
To facilitate the management of the diagnostic information, the
episodes were grouped according to the Expanded Diagnostic
Clusters (EDC) of the ACGH system. To use this system, a
conversion from the ICPC to the International Classification of
Diseases (ICD-9-CM) [20] was made beforehand, using a mapping
method developed by the research team. Thus, the ACGH system
grouped each ICD-9-CM code as a single EDC from a total of 264
EDCs in the system, based on the clinical, diagnostic and
therapeutic similarities of the diseases [21].
Multimorbidity Patterns in Primary Care
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the recent study by Salisbury et al. [22]. Here, a chronic disease
was defined as one whose duration was 6 months or more,
including past conditions that required continuing care, major
diseases with a recurrence risk and/or past diseases with continued
implications for patient management (Table S1).
This study was favourably evaluated by the Clinical Research
Ethics Committee of Aragon (CEICA). Written consent by
patients was not needed since the study does not involve
interventions on individuals, the use of human biological samples,
or the analysis of personally identifiable data. Instead, the present
work is based on the statistical analysis of anonymous data
contained in previously existing databases which were obtained
with prior permission from the corresponding entity.
Statistical analysis
Descriptive analysis. A descriptive analysis of the
population was performed by calculating the frequencies of
demographic variables. To facilitate the analysis of age, three
age ranges were created: 15–44, 45–64 and 65 and over. The
remaining analyses were performed separately for each age and
sex group. To provide an initial description of the prevalence of
multimorbidity, the frequency of EDCs per patient for each group
of age and sex was calculated.
Factor analysis. To determine the associations between
diseases that exhibited multimorbidity patterns, an exploratory
factor analysis was applied. The aim of this method was to identify
sets of variables with a common underlying causal factor. This
technique was chosen because, in addition to identifying
associations among groups of variables, it allowed for variables
to be included in the various patterns.
To increase the epidemiological interest of the study, only those
EDCs with a prevalence equal to or greater than 1% in each
group were included (Table S1). These EDCs were coded in
binary format (i.e., 0=no disease and 1=presence of the disease).
The factor analysis was based on a correlation matrix to determine
which diagnostic variables comprised each factor. Due to the
dichotomous nature of the variables, tetra-choric correlation
matrices were used [23]. In doing so, it was assumed that
dichotomous diagnoses had underlying, continuous characteristics.
That is, we assumed that the chronic diseases included in our
analysis had a progressive course (i.e., the accumulation of risk
factors before the onset and/or the progression after the onset of
the disease) and were diagnosed during this course if they reached
a certain threshold. The factors resulting from this analysis were
interpreted as multimorbidity patterns (i.e., EDCs frequently
related to each other), and each factor score, which had a value
between 21 and 1, represented the association of each of the
diagnoses with its disease pattern.
The extraction of the disease factors was performed using the
principal factor method, and it was assumed that the extracted
factors did not explain the total variance of the analysed EDCs. To
determine the number of factors to extract, a scree plot was utilised
in which the eigenvalues of the correlation matrix were
represented in descending order. The number of factors extracted
corresponds to the sequence number of the eigenvalue that
produces the inflection point of the curve [24]. In some situations,
the Heywood phenomenon was observed due to the uniquely
negative scores, which produced factor scores greater than 1. This
can occur when a small or excessive number of factors are
removed. In this case, as well as when a clear solution was not
obtained by the scree plot, a clinical evaluation of different
solutions was conducted. To facilitate the interpretation of the
factors, an oblique rotation (Oblimin) was applied.
The adequacy of the sample used to perform the factor analysis
was analysed by measuring the Kaiser-Meyer-Olkin (KMO) for
each age and sex group. This parameter takes values between 0
and 1, which are closer to 1 with a greater goodness of fit. In
addition, as a measure of model goodness-of-fit, the proportion of
cumulative variance was obtained, which describes the variability
of the diagnostic data explained by the patterns.
For determining which EDCs formed each multimorbidity
pattern, those with scores equal to or greater than 0.25 for each
factor were selected.
Given that multimorbidity is defined as the simultaneous
presence of two or more chronic diseases [1], it was agreed that
an individual had a specific pattern of multimorbidity if he/she
presented with at least two of the diseases that comprised the
pattern. Ultimately, this permitted the calculation of the
prevalence of each of the multimorbidity patterns.
STATA 11.0 software was used to conduct the statistical
analysis, and Excel 2007 was used to prepare the graphs.
Clinical consistency of the patterns
Clinical relevance was studied in three phases. First, two
qualified primary care physicians with research and clinical
experience independently reviewed the clinical plausibility of
disease interactions. Next, a joint analysis of both independent
reports was performed by a third physician specialized in public
health and experienced in health services research, identifying
agreements and disagreements between both family physicians.
Last, results were resubmitted to the primary care professionals
and discussed in a final consensus meeting. The main arguments
and conclusions were also contrasted with a literature review by
other members of the research team.
Results
Descriptive analysis
The study population consisted of 275,682 patients over the age
of 14, and 56.6% of this population was female. Figure 1 shows the
population pyramid, and Table 1 shows the population distribu-
tion of the six age and sex groups.
Multimorbidity existed in all of the studied groups (Table 2). An
increasing number of simultaneous diseases in an individual were
observed as age increased, and there were no apparent gender
differences. In younger people aged 15 to 44, 13% had more than
two simultaneous chronic diseases (11% men and 16% women),
and for patients between 45 and 64 years of age, this figure rose to
43% (39% men and 47% women). Furthermore, this percentage
Figure 1. Population pyramid, year 2008.
doi:10.1371/journal.pone.0032190.g001
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(65% men and 69% women).
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Men 15 to 44 years old. This age and sex group had a KMO
sampling adequacy index of 0.66 and a cumulative variance
percentage of 26.87% (Table 3). The scree plot for this group
indicated that the number of factors extracted was equal to two, as
the point of inflection on the curve occurred at the eigenvalue
occupying that position (Figure 2). The first factor was determined
by the association between hypertension, diabetes, obesity and lipid
metabolism disorders. The second factor was composed of
substance abuse, anxiety and neurosis, schizophrenia and affective
psychosis, lipid metabolism disorders and obesity (Table 4). In this
group, 2.07% of the individuals belonged to at least one of the two
patterns that were obtained, and there was a prevalence of 0.93%
for the first pattern and 1.53% for the second.
Men 45 to 64 years old. For this age and sex group, a KMO
value of 0.50 was obtained with a cumulative variance percentage
of 14.80% (Table 3). The scree plot again pointed to the relevance
of extracting two factors (Figure 3). The first factor was similar to
the first factor that was found for men aged 15–44 but also
included other diseases, such as ischemic heart disease, cardiac
arrhythmia, atherosclerosis, and acute myocardial infarction. The
second factor comprised obesity, arthropathy, back pain, varicose
veins in the lower extremities and gastro-oesophageal reflux
(Table 5). In this group, 13.61% of the individuals belonged to at
least one of the two patterns obtained, and there was a prevalence
of 9.20% for the first pattern and 4.86% for the second.
Men 65 years of age or older. For this age and sex group, a
KMO value of 0.57 was obtained with a cumulative variance
percentage of 22.81% (Table 3). Although the scree plot indicated
that it would be appropriate to extract 4 factors (Figure 4), the
Heywood phenomenon was observed, and it was therefore
decided that 3 factors would be extracted. The first factor was
similar to the first factors found for men 15–44 and 45–64 years of
age but also included conditions such as congestive heart failure,
anaemia and gout. In addition, there was a new factor associated
with osteoporosis, Parkinson’s disease, dementia/delirium and skin
ulcers. Moreover, the second factor for men aged 45–64, which
was now termed Factor 3, was present for this group and
incorporated new diseases, such as cervical pain, dermatitis and
eczema (Table 6). In this group, 30.99% of the individuals
belonged to at least one of the three patterns obtained, and the
prevalence of Factor 1 was 20.25%, that of Factor 2 was 1.67%
and that of Factor 3 was 13.56%.
Women 15 to 44 years old. The sampling adequacy of this
group had a KMO value of 0.71 with a cumulative variance
percentage of 24.72% (Table 3). The inflection of the scree plot
corresponded to two factors (Figure 5). The first factor, which had
a prevalence of 0.38%, was composed of obesity, hypertension and
lipid metabolism disorders. The second factor, which had a
prevalence of 2.69%, was composed of varicose veins in the legs,
iron deficiency anaemia, arthropathy, neck pain, behavioural
problems (insomnia), dermatitis and eczema and diseases of the
hair and follicles (Table 7). Overall, 3.03% of women between 15
and 44 years of age belonged to one of these two patterns.
Table 1. Population distribution according to age and sex.
15–44 years 45–64 years $65 years
n% n % n %
Men 54,705 19.8 35,587 12.9 29,361 10.7
Women 66,540 24.1 46,035 16.7 43,454 15.8
doi:10.1371/journal.pone.0032190.t001
Table 2. Distribution of the number of chronic EDCs within each age and sex group.
15–44 years 45–64 years $65 years
Men Women Men Women Men Women
N
o _ chronic EDCs N % n % n % n % n % n %
0 32,422 59.27 34,824 52.34 9,940 27.93 10,413 22.62 3,486 11.87 4,642 10.68
1 16,293 29.78 20,911 31.43 11,683 32.83 14,021 30.46 6,855 23.35 8,687 19.99
2 4,442 8.12 7,403 11.13 7,291 20.49 10,065 21.86 6,948 23.66 9,703 22.33
3 1,132 2.07 2,370 3.56 3,871 10.88 6,140 13.34 5,345 18.2 8,306 19.11
4 299 0.55 737 1.11 1,703 4.79 3,075 6.68 3,425 11.67 5,775 13.29
5 85 0.16 205 0.31 687 1.93 1,406 3.05 1,785 6.08 3,374 7.76
6 23 0.04 76 0.11 250 0.7 575 1.25 829 2.82 1,649 3.79
7 5 0.01 10 0.02 102 0.29 214 0.46 414 1.41 759 1.75
8 3 0.01 4 0.01 46 0.13 80 0.17 169 0.58 311 0.72
9 1 0 – – 10 0.03 36 0.08 74 0.25 153 0.35
10 – – – – 3 0.01 7 0.02 17 0.06 64 0.15
1 1 ––––––201 1 0 . 0 4 2 1 0 . 0 5
1 2 ––––10101060 . 0 1
1 3 ––––––––––40 . 0 1
1 4 ––––––––20 . 0 1 ––
Total 54,705 100 66,540 100 35,587 100 46,035 100 29,361 100 43,454 100
doi:10.1371/journal.pone.0032190.t002
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group had a KMO value of 0.68 with a cumulative variance
percentage of 23.70% (Table 3). The scree plot clearly
demonstrated that there was no ideal place at which to set the
cut-off point (Figure 6). As a result, a clinical interpretation of the
various options was conducted, and it was decided that three
factors should be extracted. The first factor, which had a
prevalence of 4.05%, was similar to Factor 1 obtained for
women aged 15–44 but diabetes replaced the lipid metabolism
disorders. The second factor, which had a prevalence of 11.69%,
was composed of thyroid disease, gastro-oesophageal reflux,
varicose veins in lower extremities, neck pain, back pain, anxiety
and neurosis, osteoporosis and dermatitis and eczema. This factor
was partially coincident with Factor 2 from the group of women
aged 15–44. The third factor, which had a prevalence of 0.12%,
was composed of behavioural problems (insomnia) and depression
(Table 8). Overall, 15.01% of women between 45 and 64 years of
age belonged to one of these three patterns.
Women 65 years of age or older. The sampling adequacy
of this group had a KMO value of 0.68 with a cumulative variance
percentage of 24.68% (Table 3). The scree plot indicated that it
was appropriate to extract four factors (Figure 7). The first factor,
which had a prevalence of 33.30%, was very similar to Factor 1 for
women aged 45–64 but also included diseases such as osteoporosis,
cervical pain and varicose veins in the lower extremities. The
second factor, which had a prevalence of 3.84%, was composed of
congestive heart failure, cardiac arrhythmia, iron deficiency
anaemia, cerebrovascular disease, dementia/delirium and skin
ulcers. The third factor (prevalence of 17.30%) consisted of the
association of ischemic heart disease, hypertension, diabetes,
obesity, haematological problems, cardiac arrhythmia and
congestive heart failure, and this coincided with Factor 1 for the
groups of women aged 15–44 and 45–64. In addition, the factor
that was composed of behavioural problems (insomnia) and
depression (Table 9) was also seen for this age group (prevalence of
0.16%), as it had been for women aged 45–64. Overall, 45.34% of
women 65 years of age or older belonged to at least one of these
four patterns.
Most of the studied diseases were present in one single pattern,
and only 6 of the 37 diseases that comprised the 5 patterns were
associated with more than one pattern; these included lipid
metabolism disorders (in men), obesity (in men), congestive heart
failure (in women and men), osteoporosis (in men), cardiac
arrhythmia (in women) and iron deficiency (in men).
Discussion
This study revealed five specific clinically consistent patterns of
multimorbidity in the adult population: cardio-metabolic, psychi-
atric-substance abuse, mechanical-obesity-thyroidal, psychogeriat-
ric and depressive. Two of them were found to evolve throughout
life and differed in their presentation for men and women (i.e.,
cardio-metabolic and mechanical-obesity-thyroidal), three of them
affected both sexes (i.e., cardio-metabolic, mechanical-obesity-
thyroidal and psychogeriatric), and two of them were present
exclusively in men or women (i.e., psychiatric-substance abuse and
depressive, respectively) (Table 10).
Those two patterns suggesting an evolution throughout life were
composed mainly of risk factors in the youngest age group, of
organ disorders in the middle-aged group, and of various disease-
related complications in the eldest group.
Figure 2. Scree plot for men in the 15 to 44 age range.
doi:10.1371/journal.pone.0032190.g002
Table 4. Factor score for each EDC in men 15 to 44 years of
age.
Chronic EDCs Factor1 Factor2
Disorders of lipoid metabolism 0.42 0.29
Hypertension 0.65 0.13
Diabetes 0.46 0.05
Obesity 0.45 0.26
Anxiety, neuroses 0.03 0.39
Substance use 20.08 0.53
Schizophrenia and affective psychosis 0.01 0.36
Asthma, w/o status asthmaticus 20.10 0.04
Thyroid disease 0.14 0.15
Arthropathy 0.12 20.03
Cervical pain syndromes 0.14 0.02
Low back pain 0.04 20.02
Dermatitis and eczema 0.09 0.03
Note: factor scores $0.25 have been highlighted in bold.
doi:10.1371/journal.pone.0032190.t004
Figure 3. Scree plot for men in the 45 to 64 age range.
doi:10.1371/journal.pone.0032190.g003
Table 3. KMO values and the % of accumulated variance of
the factor analysis carried out within each age and sex group.
15–44 years 45–64 years $65 years
Men Women Men Women Men Women
KMO 0.66 0.71 0.50 0.68 0.57 0.68
% Accumulated
Variance
26.87 24.72 14.80 23.70 22.81 24.68
doi:10.1371/journal.pone.0032190.t003
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association between the specific diseases that comprise these
patterns, there have been very few population-wide published
studies on multimorbidity including the non-elderly population.
Multimorbidity Patterns
Cardio-metabolic. This multimorbidity pattern was present
in both sexes and for all of the age ranges analysed. Although it was
especially prevalent among individuals 65 years of age or older (i.e.,
oneinthreewomenandoneoutofeveryfive meninthisagegroup),
the high prevalence of this patternin the middle-aged groups should
be noted (i.e., 22% in women and about 10% in men).
Its development in men and women was consistent with the
disease pathophysiology. In young patients, it was manifested as
Figure 4. Scree plot for men older than 65 years of age.
doi:10.1371/journal.pone.0032190.g004
Table 6. Factor score in each EDC in men 65 years of age and
older.
Factor1 Factor2 Factor3
Congestive heart failure 0.52 0.25 0.03
Cardiac arrhythmia 0.34 0.19 0.09
Generalised atherosclerosis 0.28 0.17 0.08
Hypertension 0.34 20.10 0.09
Diabetes 0.36 0.03 20.09
Iron deficiency, other deficiency
anaemias
0.29 0.33 0.15
Haematologic disorders, other 0.35 20.07 0.01
Obesity 0.29 20.22 0.04
Gout 0.27 20.08 0.03
Cardiovascular disorders, other 0.25 0.05 0.00
Osteoporosis 20.21 0.35 0.40
Parkinson’s disease 0.02 0.35 0.00
Dementia and delirium 20.08 0.38 0.10
Behaviour problems 0.04 0.28 0.04
Chronic ulcer of the skin 0.23 0.59 20.15
Cerebrovascular disease 0.20 0.25 0.00
Gastro-oesophageal reflux 20.06 0.09 0.30
Prostatic hypertrophy 20.07 20.04 0.31
Arthropathy 0.03 20.02 0.29
Cervical pain syndromes 20.03 20.06 0.29
Low back pain 20.01 20.02 0.36
Anxiety, neuroses 0.03 0.20 0.28
Dermatitis and eczema 0.00 0.04 0.32
Acute myocardial infarction 0.23 20.02 20.06
Ischemic heart disease (excluding infarction) 0.20 0.04 0.18
Thyroid disease 0.06 0.16 0.20
Emphysema, chronic bronchitis, COPD 0.15 0.12 0.24
Malignant neoplasms, colorectal 0.07 0.07 0.00
Disorders of lipoid metabolism 0.09 20.17 0.17
Malignant neoplasms, prostate 20.03 0.19 20.02
Peripheral neuropathy, neuritis 0.19 0.01 0.15
Cataract, aphakia 0.09 20.05 0.19
Glaucoma 0.04 0.00 0.11
Psoriasis 0.04 20.08 0.11
Deafness, hearing loss 20.04 20.11 0.14
Varicose veins of lower extremities 0.05 0.05 0.19
Low impact malignant neoplasms 0.00 0.05 0.14
Asthma, w/o status asthmaticus 20.12 20.08 0.18
Note: factor scores $0.25 have been highlighted in bold.
doi:10.1371/journal.pone.0032190.t006
Table 5. Factor score for each EDC in men 45 to 64 years of
age.
Factor1 Factor2
Ischemic heart disease (excluding infarction) 0.35 20.08
Cardiac arrhythmia 0.44 20.08
Generalised atherosclerosis 0.45 20.01
Acute myocardial infarction 0.30 20.03
Hypertension 0.42 0.14
Diabetes 0.46 20.07
Chronic liver disease 0.33 20.06
Obesity 0.27 0.26
Substance use 0.34 20.14
Emphysema, chronic bronchitis, COPD 0.36 0.09
Deafness, hearing loss 20.08 0.26
Gastro-oesophageal reflux 20.05 0.34
Varicose veins of lower extremities 0.01 0.29
Prostatic hypertrophy 0.08 0.30
Arthropathy 0.02 0.25
Low back pain 20.02 0.28
Disorders of lipoid metabolism 0.24 0.17
Haematologic disorders, other 0.21 0.02
Asthma, w/o status asthmaticus 20.08 0.23
Cervical pain syndromes 20.01 0.22
Dermatitis and eczema 0.05 0.23
Cardiovascular disorders, other 0.19 0.02
Thyroid disease 0.19 0.06
Glaucoma 0.10 0.10
Renal calculi 0.06 0.15
Peripheral neuropathy, neuritis 0.09 0.12
Anxiety, neuroses 0.17 0.10
Schizophrenia and affective psychosis 0.02 20.08
Gout 0.16 0.17
Psoriasis 0.04 0.06
Note: factor scores $0.25 have been highlighted in bold.
doi:10.1371/journal.pone.0032190.t005
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progression over time was associated with the expected compli-
cations for this type of diseases, which were primarily cardiac in
nature.
In men, this pattern presented at a young age and with a
possible common pathophysiological basis of insulin resistance,
obesity and their associated inflammatory processes, and negative
lifestyles (e.g., physical inactivity, poor diet, etc.). During middle
age, ischemic heart disease, atherosclerosis, myocardial infarction,
arrhythmias, dyslipidaemia (with a factor score very close to the
established cut-off point), substance abuse, COPD and chronic
liver disease were also observed within this pattern. Although this
study did not have access to specific information regarding tobacco
smoking, it is likely that its prevalence was high in those cases
where the abuse of other substances was also high (this information
was available). The alcohol-tobacco association could have been
the probable cause of the diseases observed, such as chronic liver
disease and other related associations. In addition, there are
possible underlying iatrogenic causes due to the use of drugs such
as statins and fibrates, which can cause the elevation of
transaminases at medium and high dosages [26]. Dyslipidaemia
was present in middle-aged individuals but was absent in men 65
years of age or older, which is inconsistent with the clinical picture
observed for this age group. It is likely that this absence was due to
an underreporting bias, given the greater relative severity of other
diseases in this group. The presence of heart failure in the group of
65 years and over could be seen as the final link in the natural
history of this cardio-metabolic disease. In our study, gout was
added to this pattern, and its association with metabolic syndrome
has recently been demonstrated [27–29].
The presence and the evolution of this cardio-metabolic pattern
revealed differences between women and men. In women,
although hypertension, obesity and dyslipidaemia were present
at a young age, diabetes did not appear until the age range 45–64.
Moreover, in this second age group, the expected cardiac
Figure 5. Scree plot for women in the 15 to 44 age range.
doi:10.1371/journal.pone.0032190.g005
Table 7. Factor score of each EDC in women between 15 and
44 of years of age.
Factor1 Factor2
Disorders of lipoid metabolism 0.33 0.16
Hypertension 0.60 0.04
Obesity 0.56 0.09
Varicose veins of lower extremities 20.02 0.36
Iron deficiency, other deficiency anaemia 0.03 0.30
Arthropathy 0.09 0.26
Cervical pain syndromes 20.04 0.32
Behaviour problems 0.04 0.27
Dermatitis and eczema 0.03 0.29
Disease of hair and hair follicles 20.09 0.26
Thyroid disease 0.14 0.25
Low back pain 0.05 0.22
Anxiety, neuroses 0.10 0.22
Asthma, w/o status asthmaticus 0.18 20.02
Note: factor scores $0.25 have been highlighted in bold.
doi:10.1371/journal.pone.0032190.t007
Figure 6. Scree plot for women in the 45 to 64 age range.
doi:10.1371/journal.pone.0032190.g006
Table 8. Factor score of each EDC in women between 45 and
64 years of age.
Factor1 Factor2 Factor3
Hypertension 0.77 20.11 0.02
Diabetes 0.58 20.10 0.02
Obesity 0.37 0.16 0.03
Thyroid disease 0.07 0.29 20.16
Gastro-oesophageal reflux 0.05 0.40 0.04
Varicose veins of lower extremities 0.01 0.26 0.07
Cervical pain syndromes 20.07 0.29 0.10
Low back pain 0.02 0.28 0.16
Anxiety, neuroses 20.01 0.34 20.16
Osteoporosis 20.03 0.25 20.14
Dermatitis and eczema 0.02 0.25 0.05
Behaviour problems 20.02 0.20 0.29
Depression 20.01 0.06 0.68
Asthma 0.03 0.18 20.01
Disorders of lipoid metabolism 0.21 0.19 20.08
Cardiovascular disorders, other 0.07 0.17 0.02
Other endocrine disorders 0.05 0.03 0.21
Glaucoma 0.16 0.12 0.11
Iron deficiency, other deficiency anaemia 20.02 0.17 20.02
Haematologic disorders, other 0.08 0.13 20.06
Low impact malignant neoplasms 0.00 0.12 20.33
Arthropathy 0.09 0.21 0.19
Peripheral neuropathy, neuritis 0.03 0.23 0.06
Note: factor scores $0.25 have been highlighted in bold.
doi:10.1371/journal.pone.0032190.t008
Multimorbidity Patterns in Primary Care
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e32190complications were not observed, contrary to what happened in
men of the same age. Oestrogenic protection and reduced smoking
have been previously reported as the primary reasons for reduced
cardiac complications in women [30]. We propose a hypothesis for
this study, which has also been examined by other authors [31–
33], holding that metabolic syndrome should not be considered as
a single, whole disease but rather that the obesity component
should be considered the index factor, which when present at an
early age of life, activates the immune system in both men and
women and leads to the development of the so-called metabolic
syndrome. Type 2 diabetes, therefore, would not be part of the
‘‘whole’’ (metabolic syndrome) but would rather be the conse-
quence of the initial condition (obesity). This, together with the
protective effect of oestrogen, would be the reason why Type 2
diabetes appeared in women after the age of 45 in this study.
Figure 7. Scree plot for women older than 65 years of age.
doi:10.1371/journal.pone.0032190.g007
Table 9. Factor score of each EDC in women 65 years of age and older.
Factor1 Factor2 Factor3 Factor4
Disorders of lipoid metabolism 0.25 20.16 0.04 20.06
Osteoporosis 0.40 20.07 20.17 20.07
Thyroid disease 0.25 0.01 0.02 20.13
Gastro-oesophageal reflux 0.44 0.13 20.14 0.09
Diverticular disease of colon 0.31 0.14 20.08 0.01
Varicose veins of lower extremities 0.30 0.03 0.05 20.02
Arthropathy 0.30 20.04 0.09 0.00
Cervical pain syndromes 0.28 20.09 20.02 0.01
Low back pain 0.34 20.06 0.05 0.07
Anxiety, neuroses 0.37 0.18 20.07 20.13
Dermatitis and eczema 0.27 0.02 0.03 0.04
Congestive heart failure 20.04 0.39 0.37 0.03
Cardiac arrhythmia 20.02 0.34 0.36 20.14
Iron deficiency, other deficiency anaemia 0.10 0.35 0.14 0.00
Cerebrovascular disease 20.03 0.36 0.08 0.08
Dementia and delirium 20.01 0.42 20.13 0.00
Chronic ulcer of the skin 20.16 0.50 0.10 0.02
Ischemic heart disease (excluding infarction) 0.09 0.18 0.29 20.06
Hypertension 0.11 20.08 0.44 0.03
Diabetes 20.13 0.04 0.46 20.02
Haematologic disorders, other 0.01 0.12 0.31 0.05
Obesity 0.13 20.25 0.30 0.13
Behaviour problems 0.17 0.19 20.06 0.39
Depression 0.06 20.06 0.05 0.79
Asthma, w/o status asthmaticus 0.23 20.02 0.12 20.01
Cataract, aphakia 0.22 20.01 0.06 0.09
Glaucoma 0.20 20.01 0.07 0.02
Generalised atherosclerosis 0.07 0.23 0.09 20.14
Cardiovascular disorders, other 0.07 0.10 0.21 0.09
Deafness, hearing loss 0.17 0.03 0.02 0.13
Peripheral neuropathy, neuritis 0.15 20.05 0.10 20.17
Emphysema, chronic bronchitis, COPD 0.15 0.18 0.05 0.00
Low impact malignant neoplasms 0.11 0.10 20.05 20.33
Other endocrine disorders 0.10 0.00 0.14 0.18
Note: factor scores $0.25 have been highlighted in bold.
doi:10.1371/journal.pone.0032190.t009
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over), this pattern was presented similarly in men and women,
amplifying this syndrome along with the various manifestations of
heart disease, including ischemic heart disease, arrhythmias and
congestive heart failure. Additionally, dyslipidaemia was absent in
this group, as observed in men of this age, and this was likely due
to the disease recording habits of professionals. In women, heart
failure may have also served as the final link in the natural history
of this cardio-metabolic pattern.
Psychiatric – Substance abuse. This multimorbidity
pattern appeared only in young men and was found to affect
2% of the individuals studied (n=837). This pattern consisted of
psychopathological processes, such as psychosis and neurosis,
which are both likely related to the toxic substance abuse that is
also present within this pattern and that commonly affects men at
this stage of life [34,35]. Psychoactive drugs may act as an
agglutinative factor leading to psychosis, which in its early stages
favours substance abuse [36,37]. This clinical picture also involves
obesity, which is a consequence of this poor lifestyle as well as the
use of new-generation antipsychotic medications [38]. This causal
hypothesis is supported by the fact that this pattern did not
appear among women, where toxic substance abuse occurs less
frequently [35].
Mechanical. In men, this was a complex pattern that could
also be denominated mechanical-obesity-thyroidal. It affected 5%
of middle-aged individuals and was found to decrease to 2%
among individuals aged 65 and over. For men aged 45–64, it is
likely that obesity acted as an index disease that favoured the
emergence of mechanical disorders due to excess body weight,
such as arthropathy, cervical and low back pain, varicose veins of
lower extremities, and gastro-oesophageal reflux [39–41]. An
increased risk for benign prostatic hypertrophy has also been
found in obese men [42]. However, this hypothesis should be
further supported since, unexpectedly, obesity does not appear in
men over 65. Instead, the factor score for thyroid problems
became very close to the established cut-off point in this age group.
The latter could explain some of the associations and interactions
between the various diseases found within this pattern. It should
finally be mentioned that for patients 65 years of age or older, this
pattern shared clear similarities with fibromyalgia [43].
In women, the mechanical pattern was manifest somewhat
differently than in men. It appeared early in life and it was never
associated with obesity but rather with thyroid problems, likely in
the form of hypothyroidism [44,45]. While the prevalence of this
pattern was 3% among women of the 15 to 44 age group, it was
very high among women aged 45 to 64 affecting more than one in
five women (22%). At this age, the pattern was amplified by
neurogenic disorders, such as anxiety and dermatitis. Finally, for
women in the 65 and over age group, the pattern was presented in
its most amplified state (i.e. arthropathy, cervical and low back
pain, varicose veins of lower extremities, gastro-oesophageal
reflux, osteoporosis and neurogenic disorders) and was associated
with various other disorders, such as dyslipidaemia or diverticu-
losis, for which the association is difficult to explain according to
available knowledge.
Psychogeriatric. This multimorbidity pattern appeared in
individuals 65 years of age and older and was the second-most
prevalent pattern after cardio-metabolic. It was more common in
women (17%) than men (14%) and was manifest in the form of
dementia, behavioural problems, Parkinson’s disease, osteoporosis,
chronic skin ulcers and iron deficiency. Heart failure and stroke
showed factor scores very close to the established cut-off-point and
are among the leading causes of dementia [46]. Dementia can also
be caused by Parkinson’s disease, and the antipsychotic treatment
of the behavioural disturbances in patients with dementia can
cause Parkinsonism [47].
The presence of dementia and Parkinson’s disease together with
age-related osteoporosis can lead to falls, fractures, the immobility
of the patients and the appearance of skin ulcers caused by bed rest
among these patients [48].
In women, this pattern was slightly different than in men:
dementia, cerebrovascular disease and chronic skin ulcers were
present. In addition, heart failure, iron deficiencies and cardiac
arrhythmia (mostly in the form of atrial fibrillation) were present in
this pattern, and these were clearly associated with and were the
cause of cerebrovascular disease [49]. Parkinson’s disease,
osteoporosis and behavioural problems disappeared in women
with respect to men.
Depressive. This multimorbidity pattern consisted of only
two conditions: depression and behavioural disorders (mainly
insomnia). These were strongly associated with one another and
were present only in women aged 45–64 and 65 years and over.
This was the least prevalent of the five patterns described, as the
frequency was less than 0.2% in both age groups. The association
between these two clinical conditions has been widely described
[50], and it has also been shown that untreated anxiety disorders
can develop into depression [51]. It is noteworthy that anxiety was
present in our study population as part of the thyroid pattern in
both men and women.
Table 10. Identified multimorbidity patterns and their prevalence within each age and sex group.
Men Women
Multimorbidity pattern Prevalence (%) Multimorbidity pattern Prevalence (%)
15–45 years Cardio-metabolic 0.93 cardio-metabolic 0.38
psychiatric-substance abuse 1.53 mechanical-obesity-thyroidal 2.69
45–64 years Cardio-metabolic 9.20 cardio-metabolic 4.05
mechanical-obesity-thyroidal 4.86 mechanical-obesity-thyroidal 11.69
depressive 0.12
$65 years Cardio-metabolic 20.25 cardio-metabolic 33.30
mechanical-obesity-thyroidal 1.67 mechanical-obesity-thyroidal 3.48
psychogeriatric 13.56 psychogeriatric 17.30
depressive 0.16
doi:10.1371/journal.pone.0032190.t010
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The two main aspects that influence result-stability are the
nature and number of individuals and diseases that are included in
the analysis [52]. The diagnoses in this study were taken from the
electronic medical records of 275,682 primary care adult patients
in the context of a national health system with universal coverage,
which has been shown to lead to more reliable and representative
conclusions compared to those derived from survey-based studies
[53].
Regarding the statistical methodology used, the exploratory
factor analysis applied in this study is the preferred method when
the objective is to explore statistically significant stable disease
clusters [54]. In the absence of inferential statistics on which to
base the analytical choices related to this type of method, the
decisions were based on a set of rules and recommendations for
the social sciences that have previously been described by Costello
et al. [55]. Thus, this study adhered to the following criteria: (a) the
use of the principal factor method as the technique for extracting
factors by assuming a nonparametric distribution of binary data
(presence/absence of disease); (b) the use of scree plots together
with a clinical assessment of the results to select the number of
factors; (c) the oblique rotation of factors; (d) factor scores greater
than 0.30, which is set as the minimum acceptable value for the
correlation to be significant from a clinical and statistical
perspective; (e) the detection of few or no diseases with strong
associations with several factors; (f) the identification of at least
three diseases per factor; (g) obtaining samples from more than 100
individuals and (h) the presentation of the factor scores.
It is noteworthy that this study met most of these standards. The
decision to reduce the minimum factor score to 0.25 (or even 0.20)
was due to the expectation that there would be a significant
number of associations among diseases due to chance (i.e.,
concurrent multimorbidity). Therefore, a more permissive thresh-
old was established. On the other hand, despite the fact that the
depressive pattern comprised only two diseases (depression and
behavioural disorders, such as insomnia), this pattern has been
previously identified in the literature [56]. Moreover, the
goodness-of-fit values for the models, expressed as the percentage
of the accumulated variance (i.e., between 14.80% and 26.87%)
and the sampling adequacy (i.e., KMO measures between 0.50
and 0.71) were above the acceptable lower limits.
Limitations
Although several hypothesis have been put forward on the
pathophysiological processes underlying the five multimorbidity
patterns brought to light in this study, the former must be interpreted
with the necessary caution since the study design (i.e. transversal) does
not allow to establish the sequence in which diseases cluster within a
pattern. Longitudinal studies would be required to corroborate the
suggested causal associations as well as to help elucidate those disease
associations that could not be explained in the present study.
As stated earlier, this study was based on information that was
recorded in the primary care electronic medical record system
during medical visits. Although there are many benefits of this
methodology, it can also limit the data. The workload of
healthcare professionals and the structure of the applied diagnostic
coding system (i.e. ICPC) often lead certain information regarding
disease history not to be recorded in the individual patient medical
histories. Therefore, the frequencies of many diseases are often
underestimated. We suspect that this may have occurred for
smoking, which is systematically underreported in a population
with a very high prevalence of smokers [57]. This led us to exclude
this information from the analysis and therefore prevented us from
providing a plausible explanation to some of the associations found
with the cardio-metabolic pattern. However, the fact that we
focused this study on chronic diseases, which have diagnostic codes
that remain in the health record over time, may have helped to
minimise this problem. Furthermore, this constraint is expected to
be minimal, given the quality criteria that were used to select the
centres included in the study.
A potential overrepresentation of certain diagnoses may exist
when these are associated with other diseases for which treatment
protocols recommend periodic health reviews. In other words, the
higher frequency of visits by patients with these diseases would
affect the likelihood that associated diseases were diagnosed (i.e.,
observer bias). To avoid this bias, future studies should be based
on the entire population rather than solely on those users of the
primary care services.
It is important to note that this work focused on chronic
diseases. Although this may ensure comparability with other large
studies across different international contexts, future research
should consider including the whole range of diseases seen in
patients. This would be especially true where the boundaries
between ‘‘chronic’’ and ‘‘acute’’ diseases are not always clear, as
was demonstrated by Starfield [58]. Often, the recurrence of acute
diseases causes them to be chronic, and they should be regarded as
chronic diseases in all of their dimensions [58].
Although the different age groups were defined according to the
expected biological homogeneity of individuals among groups, the
selected thresholds could have influenced the nature of the
obtained multimorbidity patterns. The use of different and/or
narrower age groups may be advisable in future studies.
To conclude with the potential limitations of this study, it should
be noted that this study focused on the occurrence and the
simultaneous association of diseases that were defined and
registered from the perspective of the professionals caring for the
patient and not by the patient him/herself. It is possible that many
of the disease manifestations affecting the quality of life of the
patient are not met by the defined criteria. Understanding the
diseases from this perspective would require complementary
methodological approaches that are beyond the scope of this work.
Comparison with other studies
It is difficult to compare these results with those of other studies
because of differences in the disease inclusion criteria, the study
populations and the data sources used. This study was also the first
to extend the analysis to age groups under 65. The study by
Scha ¨fer et al. [29], which was also based on a factor analysis of
clinical-administrative data for the German primary care popu-
lation over 65 years of age, identified three multimorbidity
patterns for both men and women: 1) cardiovascular and
metabolic disease-related, 2) anxiety, depression, somatoform
disorders and pain-related and 3) neuropsychiatric disorder-
related. Palomo et al. evaluated the associations between
hypothyroidism and various diseases in the Spanish population
treated in primary care [9], and these associations were found to
precisely conform to the thyroid pattern noted in this study. In the
study by Holden et al. based on surveys of Australian workers [59],
it was concluded that different health problems are grouped
beyond their physiological link with an organ or system. Britt et al.
described multimorbidity patterns in the Australian population
attended by primary care physicians [14] using the Cumulative
Illness Rating Scale (i.e., the CIRS) for the categorisation of
clinical entities. Marengoni et al. used a different statistical
technique (i.e., cluster analysis) to analyse clusters of diseases in
people older than 76 years of age [3]. This technique was also used
in the study by Cornell et al. [53], which identified six patterns of
multimorbidity among veterans of the United States. These
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support the existence of the following multimorbidity patterns:
mechanical obesity-related, metabolic, neurovascular, liver dis-
ease-related, dual diagnosis-driven (psychiatric-substance abuse);
and anxiety and depression-related.
Implications for health systems
Despite the significance of multimorbidity, especially in older
individuals, the scientific evidence provided by the clinical practice
guidelines is not appropriate for patients with multiple diseases
[60], and there is a clear gap in the design of specific intervention
programmes for the management of these patients [4]. One of the
main consequences of multimorbidity is polypharmacy, which
entails the consequent risk for drug interactions and side effects
[61]. Accordingly, this study observed examples of these
phenomena, including the possible relationship between chronic
liver disease and the treatment of ischemic heart disease with
statins in men aged 45–64 [26] and the possible interaction
between the use of antipsychotics for the behavioural alterations of
dementia and the onset of Parkinsonism after the age of 65 [47].
From the standpoint of healthcare management, strong and
developed primary care is the best solution to the complex needs of
patients with multimorbidity [62]. However, the fragmentation of
the current healthcare model hinders integrated and coordinated
care between the primary and specialised care levels and between
the healthcare and social sectors, which leads to inefficiencies in
the care of patients with multimorbidity [62].
Moreover, the importance of other approaches beyond those
based on health services, which are needed to ensure the health of
the population, should be stressed. For example, the promotion of
a healthy lifestyle is closely linked to a decline in the incidence of
obesity [63], and as this study has shown, obesity was present in
three of the patterns described (cardio-metabolic, mechanical-
obesity-thyroidal and psychiatric-substance abuse).
Finally, a change in the focus of etiologic research is required for
the study of diseases and their relationship to joint presentations,
and an analysis of underlying factors, including pathophysiolog-
ical, genetic, iatrogenic and/or socioeconomic factors should be
promoted.
Conclusion and future research
The results of this work have demonstrated that the existence of
non-random associations between chronic diseases is a reality for
the entire population, not only the elderly.
These disease associations give rise to clinically consistent
multimorbidity patterns that affect a significant proportion of the
population. Most importantly, when studying the lifetime disease
process, there are underlying pathophysiological phenomena upon
which action can be taken both from a clinical, individual-level
perspective and from a public health or population-level
perspective.
Knowledge regarding the main disease patterns and their
evolution with age should facilitate the design of tools, such as
clinical practice guidelines, treatment protocols for patients with
multimorbidity and healthcare information systems with alarm
signals to monitor for the duplication of visits and diagnostic tests,
the incidence of polypharmacy and potential adverse drug
reactions, inappropriate hospitalisations and even mortality.
All information available in the health systems should be
properly managed to maximise the individual attention given to
these patients and to ensure the efficient use of resources. This will
positively impact the overall health of the population.
The integration of information is a basic strategy that should be
accompanied by structural and functional measures that promote
coordination between different actors and levels of the care and
that ensure safe and adequate communication among the
professionals who care for such patients.
Multimorbidity is a public health problem that must be
considered by the planning and organisational frameworks of the
health system. This work aimed to provide clinically relevant
information to improve this process.
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